GENTIAN DIAGNOSTICS ASA (GENT.OL) Stock Fundamental Analysis
Europe - OSL:GENT - NO0010748866 - Common Stock
55.6 NOK
-0.2 (-0.36%)
Overall GENT gets a fundamental rating of 6 out of 10. We evaluated GENT against 59 industry peers in the Health Care Equipment & Supplies industry. While GENT has a great health rating, its profitability is only average at the moment. GENT is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year GENT was profitable.
GENT had a positive operating cash flow in the past year.
In the past 5 years GENT reported 4 times negative net income.
In multiple years GENT reported negative operating cash flow during the last 5 years.
1.2 Ratios
GENT's Return On Assets of 18.25% is amongst the best of the industry. GENT outperforms 94.92% of its industry peers.
GENT's Return On Equity of 21.37% is amongst the best of the industry. GENT outperforms 89.83% of its industry peers.
The Return On Invested Capital of GENT (7.59%) is better than 64.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROIC | 7.59% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 25.83%, GENT belongs to the top of the industry, outperforming 93.22% of the companies in the same industry.
GENT has a Operating Margin (12.10%) which is in line with its industry peers.
GENT's Gross Margin of 54.19% is in line compared to the rest of the industry. GENT outperforms 45.76% of its industry peers.
In the last couple of years the Gross Margin of GENT has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
2. Health
2.1 Basic Checks
GENT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for GENT remains at a similar level compared to 1 year ago.
The number of shares outstanding for GENT remains at a similar level compared to 5 years ago.
The debt/assets ratio for GENT has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 16.26 indicates that GENT is not in any danger for bankruptcy at the moment.
GENT has a better Altman-Z score (16.26) than 96.61% of its industry peers.
The Debt to FCF ratio of GENT is 0.33, which is an excellent value as it means it would take GENT, only 0.33 years of fcf income to pay off all of its debts.
GENT has a better Debt to FCF ratio (0.33) than 89.83% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that GENT is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, GENT belongs to the top of the industry, outperforming 88.14% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Altman-Z | 16.26 |
ROIC/WACC0.89
WACC8.51%
2.3 Liquidity
GENT has a Current Ratio of 5.47. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.47, GENT belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
GENT has a Quick Ratio of 3.78. This indicates that GENT is financially healthy and has no problem in meeting its short term obligations.
GENT has a Quick ratio of 3.78. This is amongst the best in the industry. GENT outperforms 93.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 |
3. Growth
3.1 Past
GENT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 2103.43%, which is quite impressive.
The Revenue has grown by 11.68% in the past year. This is quite good.
Measured over the past years, GENT shows a very strong growth in Revenue. The Revenue has been growing by 25.96% on average per year.
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
3.2 Future
GENT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 62.29% yearly.
The Revenue is expected to grow by 31.72% on average over the next years. This is a very strong growth
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 20.67, GENT is valued on the expensive side.
GENT's Price/Earnings ratio is a bit cheaper when compared to the industry. GENT is cheaper than 77.97% of the companies in the same industry.
When comparing the Price/Earnings ratio of GENT to the average of the S&P500 Index (27.69), we can say GENT is valued slightly cheaper.
A Price/Forward Earnings ratio of 20.49 indicates a rather expensive valuation of GENT.
61.02% of the companies in the same industry are more expensive than GENT, based on the Price/Forward Earnings ratio.
GENT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.67 | ||
| Fwd PE | 20.49 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GENT indicates a slightly more expensive valuation: GENT is more expensive than 62.71% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as GENT.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 90.58 | ||
| EV/EBITDA | 27.2 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GENT's earnings are expected to grow with 62.29% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y62.29%
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a yearly dividend of 0.74%, GENT is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 2.36, GENT has a dividend in line with its industry peers.
With a Dividend Yield of 0.74, GENT pays less dividend than the S&P500 average, which is at 2.34.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.74% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y62.29%
EPS Next 3YN/A
OSL:GENT (10/21/2025, 3:13:19 PM)
55.6
-0.2 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners25.83%
Inst Owner ChangeN/A
Ins Owners2.59%
Ins Owner ChangeN/A
Market Cap857.35M
Analysts85.71
Price Target68.34 (22.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.74% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-9.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.67 | ||
| Fwd PE | 20.49 | ||
| P/S | 5.25 | ||
| P/FCF | 90.58 | ||
| P/OCF | 43.1 | ||
| P/B | 4.34 | ||
| P/tB | 5.17 | ||
| EV/EBITDA | 27.2 |
EPS(TTM)2.69
EY4.84%
EPS(NY)2.71
Fwd EY4.88%
FCF(TTM)0.61
FCFY1.1%
OCF(TTM)1.29
OCFY2.32%
SpS10.6
BVpS12.81
TBVpS10.76
PEG (NY)0.35
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.25% | ||
| ROE | 21.37% | ||
| ROCE | 9.86% | ||
| ROIC | 7.59% | ||
| ROICexc | 12.65% | ||
| ROICexgc | 17.14% | ||
| OM | 12.1% | ||
| PM (TTM) | 25.83% | ||
| GM | 54.19% | ||
| FCFM | 5.79% |
ROA(3y)0.42%
ROA(5y)-3.57%
ROE(3y)0.25%
ROE(5y)-4.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5Y-7.11%
F-Score5
Asset Turnover0.71
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | 0.33 | ||
| Debt/EBITDA | 0.11 | ||
| Cap/Depr | 115.57% | ||
| Cap/Sales | 6.38% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 69.08% | ||
| Profit Quality | 22.43% | ||
| Current Ratio | 5.47 | ||
| Quick Ratio | 3.78 | ||
| Altman-Z | 16.26 |
F-Score5
WACC8.51%
ROIC/WACC0.89
Cap/Depr(3y)104.09%
Cap/Depr(5y)116.83%
Cap/Sales(3y)8.32%
Cap/Sales(5y)10.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2103.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-142.41%
EPS Next Y59.41%
EPS Next 2Y62.29%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.68%
Revenue growth 3Y22.3%
Revenue growth 5Y25.96%
Sales Q2Q%13.88%
Revenue Next Year31.13%
Revenue Next 2Y31.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1114.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year215.39%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y257.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8223.43%
OCF growth 3YN/A
OCF growth 5YN/A